CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 2.445
EU - Europa 1.221
AS - Asia 1.100
SA - Sud America 199
AF - Africa 188
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.159
Nazione #
US - Stati Uniti d'America 2.380
SG - Singapore 681
IT - Italia 438
CN - Cina 277
IE - Irlanda 259
BR - Brasile 188
DE - Germania 142
UA - Ucraina 134
CI - Costa d'Avorio 122
FI - Finlandia 76
IN - India 65
CA - Canada 55
RU - Federazione Russa 42
SN - Senegal 40
SE - Svezia 26
GB - Regno Unito 25
NG - Nigeria 20
KR - Corea 18
NL - Olanda 17
BE - Belgio 13
VN - Vietnam 11
AT - Austria 10
FR - Francia 9
HK - Hong Kong 9
IQ - Iraq 7
MX - Messico 7
CH - Svizzera 6
AU - Australia 5
PL - Polonia 5
AR - Argentina 4
CZ - Repubblica Ceca 4
GR - Grecia 4
TR - Turchia 4
BD - Bangladesh 3
EC - Ecuador 3
JP - Giappone 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
ES - Italia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
NP - Nepal 2
PK - Pakistan 2
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 5.159
Città #
Santa Clara 610
Singapore 461
Chandler 378
Dublin 259
Chicago 154
Jacksonville 150
Abidjan 122
Boardman 111
Catania 99
Munich 89
Cambridge 64
Lawrence 64
Civitanova Marche 57
New York 57
Andover 55
Ashburn 53
Helsinki 50
Kochi 48
Dakar 40
Toronto 40
Des Moines 35
Hefei 35
Nanjing 34
Nanchang 25
Rome 22
Wilmington 22
Beijing 21
Abuja 20
The Dalles 20
Seoul 18
São Paulo 18
Columbus 17
Milan 15
San Mateo 15
Los Angeles 14
Modica 14
Brussels 13
Grafing 12
Lappeenranta 12
Philadelphia 12
Rende 12
Shenyang 12
Bremen 11
Changsha 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Palermo 11
Tremestieri Etneo 11
Hebei 10
Houston 10
Ottawa 10
Saint Petersburg 9
Boston 8
Hong Kong 8
Rio de Janeiro 8
Tianjin 8
Turku 8
Council Bluffs 7
Redwood City 7
Brasília 6
Reggio Emilia 6
Amsterdam 5
Augusta 5
Curitiba 5
Jinan 5
Norwalk 5
San Francisco 5
San Giovanni la Punta 5
Tramonti 5
Bari 4
Brooklyn 4
Carrara 4
Falls Church 4
Genoa 4
Jyväskylä 4
Kunming 4
Montreal 4
Moscow 4
Mumbai 4
Salvador 4
Scordia 4
Seattle 4
Shanghai 4
Sydney 4
Zhengzhou 4
Bastiglia 3
Bresso 3
Campinas 3
Charlotte 3
Chennai 3
Erbil 3
Fortaleza 3
Leawood 3
London 3
Ludwigshafen 3
Modena 3
New Delhi 3
Ningbo 3
Phoenix 3
Totale 3.707
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 233
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 94
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 83
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 80
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 80
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 79
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 79
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 78
[In Process Citation] 77
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 75
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 75
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 74
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 74
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 73
Hepatic echinococcosis: clinical and therapeutic aspects 72
Kidney disease in HIV-infected patients 71
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 70
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 70
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 70
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 70
Sifilide ed HIV.Presentazione di tre casi clinici 70
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 69
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 68
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 68
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 68
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 67
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 66
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 66
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 65
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 64
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 63
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 62
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 60
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 60
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 60
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 60
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 58
Serum tumor necrosis factor in acute and fulminant hepatitis B 57
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 57
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 57
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 56
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 56
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 54
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 54
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 53
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 52
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 52
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 51
Microbial translocation in chronic liver diseases 50
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 49
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 49
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 48
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 47
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 46
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 46
HCV and HIV infection among intravenous drug abusers in eastern Sicily 45
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 45
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 45
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 45
Anxiety disorders and adherence to HAART 43
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 43
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 41
Analysis of impediments to the maintenance in care of people with HIV in Italy 41
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 40
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 40
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 39
Serum cytokines as predictors of clinical outcome in AIDS-related intestinal cryptosporidiosis 39
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 38
Sexual dysfunction in HIV plus subjects in eastern Sicily 37
Prevalence of HLA-B*5701 and access to genetic test in Sicily. A multicenter study 37
New HIV diagnosis and linkage to care in two outpatient units in South Europe 37
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 37
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 36
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 36
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 33
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 33
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 32
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 32
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 32
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 29
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 27
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 27
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 24
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 23
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 22
Evaluation of HIV transmission cluster among natives and foreigners living Italy 21
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 20
Weight gain: A possible side effect of all antiretrovirals 19
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection 19
Ageing with HIV: a multidisciplinary review 19
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 19
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 19
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 18
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 18
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 18
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 16
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: A cross sectional study of people aged 65 - 74 years and more than 75 years 16
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 16
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 16
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 15
Totale 5.052
Categoria #
all - tutte 23.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021320 4 21 47 7 69 14 29 0 35 24 52 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/202643 43 0 0 0 0 0 0 0 0 0 0 0
Totale 5.379